Inorganic and Total Arsenic Contents in Rice‐Based Foods for Children with Celiac Disease

Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain, gas, diarrhea, or bad absorption due to gluten intolerance. The only treatment for this disease consists of a lifelong gluten free diet; this is, celiac people cannot consume products containing gluten, such as wheat, barley, and rye, but they can use rice and corn. Thus, rice flour is mainly used for the manufacturing of the basic products of this population. Unfortunately, rice can contain high contents of total (t‐As) and inorganic (i‐As) arsenic. The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic (256 and 128 μg kg^?1). The daily intake of i‐As ranged from 0.61 to 0.78 μg kg^?1 body weight (bw) in children up to 5 y of age; these values were below the maximum value established by the EFSA Panel (8.0 μg kg^?1 bw per day), but it should be considered typical of populations with a high exposure to this pollutant. Finally, legislation is needed to improve the labeling of these special rice‐based foods for celiac children; label should include information about percentage, geographical origin, and cultivar of the used rice.     

Adverse Reactions to Wheat or Wheat Components

Wheat is an important staple food globally, providing a significant contribution to daily energy, fiber, and micronutrient intake. Observational evidence for health impacts of consuming more whole grains, among which wheat is a major contributor, points to significant risk reduction for diabetes, cardiovascular disease, and colon cancer. However, specific wheat components may also elicit adverse physical reactions in susceptible individuals such as celiac disease (CD) and wheat allergy (WA). Recently, broad coverage in the popular and social media has suggested that wheat consumption leads to a wide range of adverse health effects. This has motivated many consumers to avoid or reduce their consumption of foods that contain wheat/gluten, despite the absence of diagnosed CD or WA, raising questions about underlying mechanisms and possible nocebo effects. However, recent studies did show that some individuals may suffer from adverse reactions in absence of CD and WA. This condition is called non‐celiac gluten sensitivity (NCGS) or non‐celiac wheat sensitivity (NCWS). In addition to gluten, wheat and derived products contain many other components which may trigger symptoms, including inhibitors of α‐amylase and trypsin (ATIs), lectins, and rapidly fermentable carbohydrates (FODMAPs). Furthermore, the way in which foods are being processed, such as the use of yeast or sourdough fermentation, fermentation time and baking conditions, may also affect the presence and bioactivity of these components. The present review systematically describes the characteristics of wheat‐related intolerances, including their etiology, prevalence, the components responsible, diagnosis, and strategies to reduce adverse reactions.     

Gluten-related disorders: Celiac disease,wheat allergy,and nonceliac gluten sensitivity

Abstract

The consumption of gluten-free products is becoming an increased alimentary habit in the general population. The scientific unfounded perception suggesting that the avoidance of gluten would improve health or that gluten could be toxic for humans are fostering medically unjustified adherences to a gluten-free diet. Currently, only patients diagnosed with celiac disease are advised to follow a strict lifelong gluten-free diet. In the same way, patients diagnosed with IgE-mediated wheat allergy must avoid exposure to wheat in any form. In that context, a third disorder, called nonceliac gluten sensitivity, characterized by distress after gluten consumption and in which neither celiac disease nor IgE-mediated allergy plays a role, has gained increased attention in the last years. Although important scientific advances have been made in the understanding of the pathologic mechanisms behind nonceliac gluten sensitivity, this disorder is still a matter of active debate in the scientific community. In the present review, the most recent advances in the immunopathology, diagnostic biomarkers and susceptibility determinants of gluten-related diseases are summarized and discussed. Furthermore, an updated overview of the new potential therapies that are currently underway for the treatment of gluten-related disorders is also provided.     

Non‐Celiac Gluten Sensitivity: How Its Gut Immune Activation and Potential Dietary Management Differ from Celiac Disease

Non‐celiac gluten sensitivity (NCGS) is a clinical entity triggered by the ingestion of gluten‐containing grains leading to intestinal and/or extraintestinal symptoms that resolve once the gluten‐containing foodstuff is eliminated from the diet, and it is diagnosed when celiac disease (CD) and wheat allergy (WA) have been ruled out. The limited knowledge about the pathophysiology of NCGS and the lack of validated biomarkers are still major limitations for clinical studies, making it difficult to differentiate NCGS from other gluten‐related disorders (GRD). In the absence of clear‐cut diagnostic criteria, NCGS is still mainly a diagnosis of exclusion. Several studies suggest that NCGS is an immune‐mediated disease that likely activates an innate immune response. Moreover, it has recently been hypothesized that in addition to gluten, other components of wheat may be responsible for the symptoms observed in individuals without CD. This review aims at discussing available evidence related to the histological and immunological features in the gut mucosa of patients with NCGS and at outlining new dietary opportunities for these patients.     

Creating hypo-/nonallergenic wheat products using processing methods: Fact or fiction?

Wheat allergy is a potentiallylife-threatening disease that affects millions of people around the world. Food processing has been shown to influence the allergenicity of wheat and other major foods. However, a comprehensive review evaluating whether or not food processing can be used to develop hypo-/nonallergenic wheat products is unavailable. There were three objectives for this study: (1) to critically evaluate the evidence on the effect of fermentation, thermal processing, and enzyme or acid hydrolysis on wheat allergenicity so as to identify the potential for and challenges of using these methods to produce hypo-/nonallergenic wheat products; (2) to identify the molecular effects of food processing needed to create such products; and (3) to map the concept questions for future research and development to produce hypo-/nonallergenic wheat products. We performed literature research using PubMed and Google Scholar databases with various combinations of keywords to generate the data to accomplish these objectives. We found that: (1) food processing significantly modulates wheat allergenicity; while some methods can reduce or even abolish the allergenicity, others can create mega allergens; and (2) fermentation and enzymatic hydrolysis hold the most potential to create novel hypo-/nonallergenic wheat products; however, preclinical validation and human clinical trials are currently lacking. We also identify five specific research concepts to advance the research to enable the creation of hypo-/nonallergenic wheat products for application in food, medical, and cosmetic industries.     

Novel Approaches in Gluten‐Free Breadmaking: Interface between Food Science,Nutrition, and Health

The evidence that celiac disease is one of the commonest food intolerances in the world is driving an increasing demand for gluten‐free foods. However, gluten is a structure‐building protein essential for formulating leavened baked goods. Therefore, obtaining high‐quality gluten‐free bread (GFB) is a technological challenge. This review focuses on contemporary approaches in gluten‐free baking that allow improvements at the structure, texture, acceptability, nutritive value, and shelf life of GFB. Gluten‐free breadmaking is a relatively new, emerging research topic that is attracting worldwide attention in order to develop different kinds of GFB, including regional varieties. Several approaches have been used to understand and improve GFB systems by evaluating different flours and starch sources, ingredients added for nutritional purposes, additives, and technologies or a combination of these elements. Some studies aimed to assess or improve GFB's technological or nutritional properties, while others had multiple objectives. Several studies used food science tools in order to improve technological and sensory quality of GFB, together with nutritional value. Some GFBs are vehicles of nutrients and bioactive compounds. Furthermore, extensive research on interfacing food science, nutrition, and health is needed so that a GFB with both good technological and nutritional properties can be prepared and made more available to those with celiac disease, which will help them adhere to a strict gluten‐free diet, increase social inclusion, and improve their quality of life.     

乳糜泻动物模型研究进展

乳糜泻是一种携带遗传易感基因的人群因摄入麸质蛋白而引起由T细胞介导的复杂肠道疾病。麸质蛋白是小麦、大麦、黑麦等谷物中的主要贮藏蛋白,由麦醇溶蛋白和麦谷蛋白组成,是诱发乳糜泻的主要环境因素。患者终生严格执行无麸质饮食是目前治疗乳糜泻的最佳方法。然而,在生活中,患者难以完全避免摄入麸质蛋白,且长期的无麸质饮食将影响患者的社会交往活动,加重患者的心理与经济负担。因此,有必要研究新的冶疗方法或药物以用于辅助或替代无麸质饮食疗法。为了验证新方法的有效性和安全性,构建动物模型模拟乳糜泻的病症是必须的。因此,本文着重介绍了判断乳糜泻动物模型是否成功建立应选取的检测指标、乳糜泻动物模型的致敏方式及目前已建立的动物模型特点,为进一步完善乳糜泻动物模型提供参考。     

高粱食品:一种古老作物带来新的健康

高粱是一种古老的作物初次被驯化于非洲,并在公元前3000年左右推广到了世界各地.高粱是一种抗旱的谷类作物,生长在其它作物无法生存的半干旱气候条件下,在2002年世界高粱产量达到5450万公吨.美国高粱年产量可达1300～1500万公吨左右,其中30%～50%用于出口,在西方国家中用高粱喂养动物已非常普遍,大约世界高粱产量的40%被用于作为非洲和印度等国家人民的食物.在美国对于患有腹乳糜泻疾病无法适应面筋蛋白的人已经用白色食品级的杂交作物生产出运用于无小麦产品作为食用,不能食用小麦或其它谷类作物比如黑麦,大麦,他们提供了些刺激性小的面粉已成为用于制造无小麦食品的原料.当高粱缺乏面筋时,高粱粉便不能生产有黏性和弹性的生面团,因此蛋奶糊配方被用于制造高粱产品,包括面包威化饼干、面条和比萨饼皮,这些原来都是由面粉制成.研究表明,高粱系生产高质量食物,因此种植高梁将被用于改善提高食物质量,最近一些研究表明由于这种古老作物包括含有二十烷醇(policosanols)的多酚复合物和高粱蜡的高抗氧化水平,可能对健康有独特的益处,对于保护心血管的健康至关重要.尤其在把小麦作为主要食物的西方世界,对于给患有腹乳糜泻疾病的人们提供了健康稳定的主食是一个挑战.因此高粱这种古老的作物作为21世纪的主要谷类作物引来了新的兴趣和前途,这是由于(1)它对于患有腹乳糜泻疾病的人是一种富有潜力的主食.(2)保持食物的营养和健康的高抗氧化水平和蜡含量.(3)由于它的抗干旱性和有限供水量的高生产量,2030年预期人口指数增长明显.     

黑小麦加工利用的研究进展及前景展望

黑小麦是由小麦和黑麦通过杂交培育出来的新品种。相比于普通小麦,黑小麦在其营养性、功能性、科学性、食疗性等多方面有着很大的优势,能够满足现代人对食品的营养价值和保健功能的要求。但目前国内外对黑小麦的开发利用仍然很少。此外,黑小麦的利用单一,普及度不高。汇总国内外对黑小麦的研究,从黑小麦的营养特性,加工利用方面综合分析和展望黑小麦的发展前景,为黑小麦加工利用提供一定的依据。     

Inorganic arsenic content in Ecuadorian rice-based products

Arsenic intake in the world is linked with drinking water and food; the main sources of inorganic As (i-As) exposure in food are rice and rice-based products. The consumption of rice in Ecuador is 53.2 kg year^?1 and it is the most commonly used cereal for the preparation of many popular dishes especially for subjects with celiac disease. Objectives of this research were: (i) to determine the content of i-As in foods widely consumed by Ecuadorians with celiac disease, (ii) to calculate the i-As dietary intake, and (iii) to model and predict the health risks of the population under study as a result of their exposure to i-As from rice-based food. The estimated daily intakes of Ecuadorian children (below 3 years of age) and adults were established at 0.52 and 0.55 μg kg^?1 body weight d^?1, respectively. These values were above the lower BMDL₀₁ value established for i-As established by the EFSA; consequently, it can be concluded that health risk cannot be excluded for the Ecuadorian population with celiac disease.     

酸面团发酵技术在无麸质食物中的应用

无麸质食物是为乳糜泻人群应对麸质蛋白过敏而生产的一类食物,但无麸质食物因麸质蛋白的缺失,多存在口感差、体积小和硬度大等缺点。酸面团是一种传统发酵技术,通过酸面团中微生物的代谢作用,可产生蛋白酶降解麸质蛋白,同时还能提高无麸质食物的整体品质,如改善制品风味、提高营养价值、延长货架期等。本文主要对酸面团发酵技术及其在无麸质食物中的应用优势进行探讨,以期为无麸质食物研究提供理论参考。     

How Looking for Celiac‐Safe Wheat Can Influence Its Technological Properties

Because of the continuous increase in the prevalence of gluten‐related disorders, selection of wheat with a low content of immunogenic gluten epitopes could be an innovative alternative for prevention. In this review, the focus is on literature data concerning the deallergenization tools of wheat, which are mainly related to breeding approaches (classic and advanced) and processing operations (germination and fermentation). Until now, no safe wheat genotype has been identified, whereas decreasing wheat allergenicity is possible. On the other hand, the decrease of gluten or some of its epitopes can strongly affect technological properties. Thus, obtaining celiac‐safe gluten without affecting the technological properties of wheat could be considered as a new challenge that scientists will be facing. Celiac‐safe wheat‐based product development could be a great revolution in the market of foods for special medical purposes. The present paper is aiming to: (a) review the strategies and the approaches used, or that can be used, for developing low allergenic wheat: their utilities and limits were also discussed and (b) screen the impact of gluten reduction or removal on the quality of wheat end‐use products.     

Gluten contamination of cereal foods in Canada

Persons suffering from celiac disease (CD) must avoid foods containing gluten or those contaminated with wheat, barley, or rye. This study was designed to estimate gluten contamination of cereal-based foods available in Canada, whether labelled gluten-free or not. About half of the 148 foods sampled were labelled as gluten-free. According to R5-enzyme-linked immunosorbent assay (ELISA), twenty-three cereal-based foods (or 15%) contained more than 20 mg of gluten per kg, including sixteen regular and seven gluten-free foods, the latter being the least contaminated. When used in combination with R5-ELISA, AOAC-ELISA (not detecting barley) was a simple and efficient tool to roughly estimate the nature of the gluten contamination, which was later confirmed by real-time polymerase chain reaction for barley, and wheat/barley/rice. Rice-, corn- or quinoa-based foods were the safest for celiac patients. In addition to misleading food labelling for both gluten-rich and gluten-free foods, critical issues for persons with CD included foods made with oats or buckwheat (contaminated with wheat and barley gluten) in addition to those, such as breakfast cereals, specifically enriched with barley malt ingredients.     

免疫检测新技术在食品检测中的应用

免疫分析技术具有特异性强、灵敏度高、方便快捷、检测成本低、安全可靠等优点,已成为现代生命科学的重要研究手段,在食品安全检测中有着良好的应用前景。本文综述了近几年来出现的免疫分析新方法,简单介绍了它们的特点及在食品安全检测中的应用。     

微波技术在食品加工与检测中应用

微波技术在现代高新技术领域具有重要地位,具有快速、节能、清洁等优点;目前微波技术发展很快、涉及面也很广,在食品加工和检测方面得到广泛应用.该文介绍微波技术在食品加工和检测中研究与应用进展.     

Gluten weight in ancient and modern wheat and the reactivity of epitopes towards R5 and G12 monoclonal antibodies

Differences in the level of coeliac‐active gluten epitopes in wheat might have some significance for individuals reporting noncoeliac gluten sensitivity. The aim of this study was to compare the reactivity of epitopes towards ELISA R5 and G12 monoclonal antibodies in ancient (emmer; Khorasan wheat; spelt) and modern wheat (common bread wheat; durum), and to check whether the bread‐making process leads to the degradation of epitopes. Data from ELISA R5 and G12 did not match gluten dry weight in wheat. Bread dough fermentation and extensive baking did not change the reactivity of coeliac‐active epitopes towards monoclonal antibodies. Compared to hexaploid bread‐type wheat (spelt; common bread wheat), ancient and modern pasta‐type tetraploid wheat (emmer; Khorasan; durum) had less epitopes reactive towards ELISA R5 and G12 and might be preferable for wheat‐sensitive individuals looking for food with reduced coeliac‐active epitopes.     

The Fate of Mycotoxins During the Processing of Wheat for Human Consumption

Mycotoxins are a potential health threat in cereals including wheat. In the European Union (EU), mycotoxin maximum levels are laid down for cereal raw materials and final food products. For wheat and wheat‐based products, the EU maximum levels apply to deoxynivalenol (DON), zearalenone, aflatoxins, and ochratoxin A. This review provides a comprehensive overview on the different mycotoxins and their legal limits and on how processing of wheat can affect such contaminants, from raw material to highly processed final products, based on relevant scientific studies published in the literature. The potential compliance with EU maximum levels is discussed. Of the four mycotoxins regulated in wheat‐based foods in the EU, most data are available for DON, whereas aflatoxins were rarely studied in the processing of wheat. Furthermore, available data on the effect of processing are outlined for mycotoxins not regulated by EU law—including modified and emerging mycotoxins—and which cover DON derivatives (DON‐3‐glucoside, mono‐acetyl‐DONs, norDONs, deepoxy‐DON), nivalenol, T‐2 and HT‐2 toxins, enniatins, beauvericin, moniliformin, and fumonisins. The processing steps addressed in this review cover primary processing (premilling and milling operations) and secondary processing procedures (such as fermentation and thermal treatments). A special focus is on the production of baked goods, and processing factors for DON in wheat bread production were estimated. For wheat milling products derived from the endosperm and for white bread, compliance with legal requirements seems to be mostly achievable when applying good practices. In the case of wholemeal products, bran‐enriched products, or high‐cereal low‐moisture bakery products, this appears to be challenging and improved technology and/or selection of high‐quality raw materials would be required.     

Nonthermal Plasma–Liquid Interactions in Food Processing: A Review

Nonthermal processing methods are often preferred over conventional food processing methods to ensure nutritional quality. Nonthermal plasma (NTP) is a new field of nonthermal processing technology and seeing increased interest for application in food preservation. In food applications of NTP, liquid interactions are the most prevalent. The NTP reactivity and product storability are altered during this interaction. The water activated by NTP (plasma‐activated water [PAW]) has gained considerable attention during recent years as a potential disinfectant in fruits and vegetable washing. However, detailed understanding of the interactions of NTP reactive species with food nutritional components in the presence of water and their stability in food is required to be explored to establish the potential of this emerging technology. Hence, the main objective of this review is to give a complete overview of existing NTP–liquid interactions. Further, their microbial inactivation mechanisms and the effects on food quality are discussed in detail. Most of the research findings have suggested the successful application of NTP and PAW for microbial inactivation and food preservation. Still, there are some research gaps identified and a complete analysis of the stability of plasma reactive species in food is still missing. By addressing these issues, along with the available research output in this field, it is possible that NTP can be successfully used as a food decontamination method in the near future.